UREA CREAM [BIOCOMP PHARMA, INC.]

UREA CREAM [BIOCOMP PHARMA, INC.]
PDF | XML

NDC 44523-617-01, 44523-617-03, 44523-617-07
Set ID 6774a5ef-9bb0-4e7a-e053-2a91aa0af47f
Category HUMAN PRESCRIPTION DRUG LABEL
Packager BioComp Pharma, Inc.
Generic Name
Product Class
Product Number
Application Number
  • SPL UNCLASSIFIED SECTION

    Rx Only


    FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

  • DESCRIPTION:

    Each gram contains 400 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, dimethyl isosorbide, glyceryl stearate, mineral oil, petrolatum, propylene glycol, purified water, sodium hydroxide and xanthan gum.


    Urea is a diamide of carbonic acid with the following chemical structure:

    structure.jpg

  • CLINICAL PHARMACOLOGY:

    Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.


    Pharmacokinetics: The mechanism of action of topically applied urea is not yet known.

  • INDICATIONS:

    For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

  • CONTRAINDICATIONS:

    This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

  • WARNING:

    KEEP OUT OF REACH OF CHILDREN.

  • PRECAUTIONS:

    FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.


    General: This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.


    Information for Patients: Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes.

    Carcinogenesis, Mutagenesis and Impairment of Fertility: Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.


    Pregnancy:Category C. Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.


    Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

  • ADVERSE REACTIONS:

    Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

  • DOSAGE AND ADMINISTRATION:

    Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.


    Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.

  • STORAGE:

    Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

    NOTICE: Protect from freezing and excessive heat. Keep bottle tightly closed.

  • HOW SUPPLIED:

    1 oz. (28.35 g) bottles, NDC 44523-617-01
    3 oz. (85 g) bottles, NDC 44523-617-03
    7 oz. (198.4 g) bottles, NDC 44523-617-07

    To report a serious adverse event or obtain product information, call (866) 762-2365.

    Manufactured for:
    BIOCOMP PHARMA, INC.
    San Antonio, TX 78230 1355
    827650 R0218

  • PRINCIPAL DISPLAY PANEL

    carton1.jpglabel1.jpglabel2.jpglabel3.jpg

  • INGREDIENTS AND APPEARANCE
    UREA 
    urea cream
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:44523-617
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    UREA (UNII: 8W8T17847W) (UREA - UNII:8W8T17847W) UREA400 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    CARBOMER INTERPOLYMER TYPE A (55000 CPS) (UNII: 59TL3WG5CO)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    DIMETHYL ISOSORBIDE (UNII: SA6A6V432S)  
    PETROLATUM (UNII: 4T6H12BN9U)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    WATER (UNII: 059QF0KO0R)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:44523-617-011 in 1 CARTON03/15/2018
    128.35 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    2NDC:44523-617-0385 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product03/15/2018
    3NDC:44523-617-07198.4 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product03/15/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other03/15/2018
    Labeler - BioComp Pharma, Inc. (829249718)
    Establishment
    NameAddressID/FEIBusiness Operations
    Mission Pharmacal Company927726893manufacture(44523-617) , label(44523-617) , analysis(44523-617) , pack(44523-617)